On October 3, 2018 Ophthotech Corporation (Nasdaq: OPHT) reported that Keith Westby, Chief Operating Officer, will present an overview of the Company at Chardan’s 2nd Annual Genetic Medicines Conference, on Tuesday, October 9, 2018 at 8:30 a.m. Eastern Time (Press release, Ophthotech, OCT 3, 2018, View Source [SID1234529723]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the presentation on the Events & Presentations section on the Ophthotech website at www.ophthotech.com. An archived replay of the webcast will be available on the Company’s website immediately following the conference.